Re: Possible reason ? Thank you for the explanation LS1.DDP
a sh*t company with an incompetent board who have nothing but contempt for their shareholders.....rest assured the BoD will be held responsible. Kibo will be the winners in the battle. The BoD should hang their heads in shame
...okay, I can live with that... ....all these guys are doing a great job in the most arduous of circumstances with everything possible being stacked against them to make life even tougher....As for all the 'boneheads' on here saying THE END ....ADMIN....ITS ALL OVER.....and I include you John Henry in this lot.....you were like the witches in Macbeth....shame on you.We are down....but not out yet...bravo to the Board and all the staff at Tonkolili and Pepel.
AGM statement Very positive AGM statement - happy to continue holding even given recent gainsFD
Re: Publication of Bond Prospectus I feel certain that "in country benefication" will have a dramatic effect on the share price!! Can't wait for more good news!
SUMI AGRO France SAS www.sumiagro.frThe notes at the end of the RNS are well worth studying. Exclusive Licence Agreement with SUMIAGRO France SAS for grape protection products Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has signed an exclusive Licence Agreement with Sumi Agro France SAS ("Sumi Agro" to sell 3AEY, an Eden-developed plant protection product in France. In addition, Sumi Agro will have the right to trial, register, develop and sell certain other plant protection products for use in France using Eden's natural encapsulation technology, GO-E Inside. The Licence Agreement, which lasts for 20 years, covers the use of 3AEY in a number of agricultural applications and the initial targeted use will be on grapes for control of Botrytis, a fungus that affects many plants and is a major concern across Europe. This follows the news announced on 21 November 2014 that Eden signed an exclusive Licence Agreement with Sipcam Italia Spa and Sipcam Iberia to sell 3AEY in Italy and Spain, respectively. Under the terms of the agreement, Eden will receive an upfront payment followed by a number of milestone payments relating to the approval of the product by the EU, which is expected in spring 2015, and sales targets. Eden will also receive ongoing royalty payments based on product sales. Sean Smith, Chief Executive Officer of Eden, said: "France is a well-known grape growing country where the market for Botryticides is, historically, the largest in the world. Ensuring that we have the right partner which is able to fully exploit the opportunities for effective products such as 3AEY in this market is, therefore, critical. We strongly believe that SUMIAGRO France is that partner and expect that Eden will benefit greatly from the weight that their name and expertise carries in France. Beyond this agreement and 3AEY, we look forward to developing other product opportunities with Sumi Agro France as well as with affiliated Sumitomo Corporation companies. " Antoine Meyer, President of Sumi Agro, said: "We fully recognize that, with 3AEY, Eden's technology is clearly an innovative BioControl answer to vineyard growers looking to satisfy their workers' concerns and consumers' demand: 3AEY botryticide provides distributors and growers with a new tool adapted to modern and increasingly sustainable farming. This agreement expresses our Sumi Agro commitment to invest in modern crop protection solutions based on conventional as well as BioControl tools." Eden Research plc www.edenresearch.comSean Smith, Chief Executive OfficerTel: 01993 862 761Alex Abrey, Chief Financial OfficerW H Ireland Limited Tel: 0117 945 3471John Wakefield / Ed AllsoppWalbrook PR LtdTel: 020 7933 8780 or [email protected] McManusMob: 07980 541 893Lianne CawthorneMob: 07584 391 303 Notes: Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products. Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic hydrophobic compounds. The technology uses yeast cells that are a by-product of numerous commercial production processes to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries. Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be
NEW ARTICLE: Upgrade for Solid State may not be the last "LSE:SOLI:Solid State's share price is 20 times higher than it was five years ago. A knack for well-timed acquisitions and highly geared to economic recovery, the maker of hardwearing computers and electronic kit shows few signs of slowing down. ..."[link]
On the plus side, way over mid !
Re: MSMN AGM fun and games Hi M33, Only just read your comments on here.. been laid up in the orthopedics ward since Thursday last.The reason for abstention on this topic I suspect is that investors are only checking the daily prices and not what is happening behind the scenes. This now appears to be the trend. "Chasing the quick buck" and not taking notice of what is occurring between races and retraces. Bit more reading required by me too I think.... Keep up the good work M.. (Hows Jan? not seen her posting for a wee whily now.B_B
STOB, Chart breakout From Base..... STOB Stobart Group ...recovery stock managed to get debt right down, Oil price will certainly help profits going FWD ...... bought a modest amount this morning. [link]
New board So has anything changed or do we have some new people who are going to give themselves some tasty share options but say cut costs, we shall see.We all know how big this share could be but if the Kazakh gov do not want us to progress for some self interest by just sitting on this deal and the gas negotiations what can we do.Maybe someone knows its good to put the squeeze on us what with our Tajik assets and all.
Re: Update "The major contract may distort comparisons in the near term and we need some "base case" figures in order to make a sensible valuation"I am sure we will get this at the results stage. They have done so on previous announcements. At the 9 month stage underlying (i.e. excluding special projects) sales were up 9%. Bear in mind the special projects may be one offs, but they are using resources which, when the projects have finished, will be spare capacity to grow the underlying figures too. This is just a quick snap shot 7 hours after the period end. They can give accurate turn over figures, but profit figures take a bit more working out.
Re: Google Play Fitbit showing 1-5M on Google Play and have 70% market share in US.Fitbug taking on Fitbit in marketing and branding dispute. Seems like its all too late to me. I am OUTShould have DMOR !
no RNS????
chairman buys 500k shares about time as well .well theres obviously a closed period but hey this is the first director buy if im not mistaken,perhaps theres a sale in the pipeline?
Latest from the Community...
Latest from the Community...
Latest from the Community...